pharma · infections · Not applicable (submitted trial is a BE study in healthy participants)
Zaklady FarmaFarmaceutyczne Polpharma
Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
Zaklady FarmaFarmaceutyczne Polpharma is a pharma organization headquartered in EU. Primary therapeutic focus areas include infections, Not applicable (submitted trial is a BE study in healthy participants), infection. N
Company details
- Status
- Public
- HQ
- EU
- Programs
- 6
- Drugs
- 15
- Patents
- 0
Pharmacokinetic study of colistimethate sodium
Phase 1 · other · serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options
Pharmacokinetic study of colistimethate sodium for serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options is a Phase 1 program (other) at Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
- Phase
- Phase 1
- Modality
- other
- Indication
- serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options
- Status
- active
- Trials
- 1